Ultralife Corporation (NASDAQ:ULBI) reported operating income of $1.0 million on revenue of $19.9 million for the quarter ended December 31, 2014. For the fourth quarter of 2013, the Company reported operating income of $0.2 million on revenue of $20.2 million. On Thursday shares of Ultralife Corp. (NASDAQ:ULBI) closed at $3.42. Company’s sales growth for last 5 years was -20.20% and EPS growth for next 5 years is recorded as 17.50%.
Shares of Voxeljet AG (NASDAQ:VJET) have earned an average broker rating score of 3.00 (Hold) from the three brokers that cover the company, Zacks Investment Research reports. Three investment analysts have rated the stock with a hold rating. Voxeljet AG (NYSE:VJET) in last trading activity advanced 7.34% to close at $9.95. Company weekly performance is 19.74% while its quarterly performance stands at -17.77%. Voxeljet AG (NYSE:VJET) is -73.46% away from its 52 week high.
Groupon, Inc. (NASDAQ:GRPN) reported net income for the fourth quarter of $8.8 million or $0.01 per share, compared to a net loss of $81.2 million or $0.12 per share for the year-ago quarter. On Thursday shares of Groupon, Inc. (NASDAQ:GRPN) closed at $7.46. Company’s EPS growth for next 5 years is recorded as 27.33%.
Microsoft Corporation (NASDAQ:MSFT) Chief Executive Officer Satya Nadella has a new strategy to make the company a purveyor of popular mobile applications: Acquire them. The software company is planning over the next few months to buy mobile-productivity applications that work on Apple Inc. and Google Inc. operating systems, according to people familiar with the situation. Microsoft Corporation (NASDAQ:MSFT) in last trading activity increased 1.68% to close at $43.09. Company weekly performance is 1.51% while its quarterly performance stands at -11.26%. Microsoft Corporation (NASDAQ:MSFT) is -13.36% away from its 52 week high.
Verastem, Inc. (NASDAQ:VSTM), announced that VS-5584 has received orphan drug designation from the U.S. Food and Drug Administration for use in the treatment of mesothelioma. The designation was created to encourage the development of drugs that may provide significant benefit to patients suffering from rare diseases. On last trading day Verastem, Inc. (NASDAQ:VSTM) advanced 0.72% to close at $8.37. Its volatility for the week is 7.31% while volatility for the month is 7.79%. Verastem, Inc. (NASDAQ:VSTM) monthly performance is -6.38%.